Skip to main content
/
Biotest Aktiengesellschaft (ETR:BIO3)
Germany flag Germany · Delayed Price · Currency is EUR
30.00
0.00 (0.00%)
Apr 24, 2025, 7:51 AM CET

ETR:BIO3 Revenue

In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M EUR with 6.08% growth. Biotest Aktiengesellschaft had revenue of 203.50M in the quarter ending December 31, 2024, with 10.42% growth.

Revenue
726.20M
Revenue Growth
+6.08%
P/S Ratio
1.97
Revenue / Employee
291.06K
Employees
2,495
Market Cap
1.43B

Revenue Chart

Created with Highcharts 11.4.8ETR:BIO3 Revenue - Annual484.2M​484.2M515.6M​515.6M516.1M​516.1M684.6M​684.6M726.2M​726.2M20202021202220232024-200M400M600M

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024726.20M41.60M6.08%
Dec 31, 2023684.60M168.50M32.65%
Dec 31, 2022516.10M500.00K0.10%
Dec 31, 2021515.60M31.40M6.48%
Dec 31, 2020484.20M65.10M15.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.44B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Biotest Aktiengesellschaft News

More News